This programme is part of the Irish Cancer Society’s Women’s Health Initiative (WHI), the aim of which is to improve health and wellbeing for women impacted by cancer who are dealing with the side effects and consequences of treatment.
Phases of thisisGO
Phase 1 was launched on September 20th 2021. It is a personalised online resource for women impacted by cervical cancer. If you have a partner in your life, this platform can also support them. If you are a health care provider working in the area this can also support you and your practice.
If you are newly diagnosed, receiving treatment, in surveillance or living well with and beyond cancer thisisGO.ie has information that is tailored to meet your needs.
Phase 2 covered ovarian cancer and was launched on the 4th of February 2022
Next Phase due shortly will cover Genetic Cancers including BRCA and Lynch Syndrome
It is hoped that the remaining three gynaecological cancer and GO cancer genetics will be complete before the end of 2022.
“Tumours that are MSI high have a lot of mutations on their surface. A lot of mutations are needed for the immune system to recognise the cancer. For the majority of solid tumours, the immune system doesn’t really care that you have cancer. But in tumours that are MSI-High, they have a lot of proteins on their surface that are kind of like signs for the immune system to say ‘Hey, I’m here! Come fight me!’ And then the immune system sees those mutations, kicks in, and sends T cells.”
If the tumour is dMMR/MSI-H, additional tests are required to determine if the MSI-H is caused by Lynch syndrome….”
Dr Doireann O’Leary (@WorldOvarianCancerDay @RTEToday) talks about the importance of being symptom aware and shares the meaning of BEAT.
She also talks about the importance of ‘the big T’, ie getting Treatment early. If someone has these symptoms it likely is something less serious than Ovarian Cancer but the most important thing is not to brush it off, do go to your GP and get checked and try to get in to the habit of doing that. Building this habit greatly increases the chances of early diagnosis.
“This is the first time that HE4 has ever been evaluated in a primary care setting, so it will be exciting to see larger-scale studies implemented to further assess its effectiveness as a diagnostic aid. Earlier diagnosis will have important implications for women’s treatment, care and ultimately, survival.”
If you have been diagnosed with Lynch syndrome, you have may questions about your medical care. This page from the USA has information on cancer risk, screening, prevention and treatment for people with an inherited mutation in a Lynch syndrome gene.
A vaccine against cancers caused by Lynch syndrome — an inherited disorder — will be among the first to test if a vaccine can stop nonviral cancers from appearing. The Lynch trial is among several looking to test a new generation of preventative cancer vaccines.
Recently, scientists have discovered that a type of immune cell known as a T cell is capable of recognizing the unique signatures of a tumor cell — and giving them the business.
Therapies designed to increase T cell’s killing power and ability to target cancer after it appears have already been approved, and they can be quite successful at treating some cancers. (More recent work is recruiting another type of immune cell, the awesomely named natural killer cells, to fight cancer.)